McKesson Unveils PATH Pro Post-Acute Therapeutics Formulary Management Program

McKesson has introduced the Path Pro Post-Acute Therapeutics Formulary Management Program for long-term care pharmacies.

Path Pro indicates which of the most commonly dispensed generic drugs in the LTC setting are preferred and non-preferred for geriatric patients — all with an eye toward helping reduce drug-related hospital readmissions.

McKesson collaborated with the Creighton University Center for Drug Information and Evidence Based Practice to create the program. Its key elements include a preferred drug list, preferred/non-preferred indication for geriatric patients and drug monographs. — Anisa Jibrell